A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

NCT02748993 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: PAC-14028 Cream 0.1%
DRUG: PAC-14028 Cream 0.3%
DRUG: PAC-14028 Cream 1.0%
DRUG: PAC-14028 Cream Vehicle

Sponsor

Amorepacific Corporation